TITAN Medical Inc.

200 articles about TITAN Medical Inc.

• Titan Medical Announces Corporate Update and Provides Bi-Weekly MCTO Status Update

  5/29/2023

  Titan Medical Inc. announced a corporate update and is also providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders.

• Titan Medical Signs License Agreement with Intuitive Surgical

  5/26/2023

  Titan Medical Inc. announced that the Company has entered into a license agreement with Intuitive Surgical, Inc., a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, for an upfront payment of US$7.5 million in respect of certain intellectual property of Titan.

• Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process

  12/7/2022

  Titan Medical Inc. today announced that in view of the commencement of the strategic review process announced on November 30, 2022, the special meeting of its shareholders scheduled for January 12, 2023 will be suspended and, if appropriate and necessary, rescheduled to a future date.

• Titan Medical Announces American Association of Gynecologic Laparoscopy Global Congress Participation

  11/17/2022

  Titan Medical Inc. today announced its attendance at the American Association of Gynecologic Laparoscopy (AAGL) 51st Global Congress on minimally invasive gynecologic surgery (MIGS) being held December 1-4, 2022 in Aurora, Colorado.

• Titan Medical Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery

  9/22/2022

  Titan Medical Inc. announced the publication of international patent application No. PCT/CA2022/050392, which the company anticipates pursuing in the United States and other key markets under the Patent Cooperation Treaty.

• Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer

  6/30/2022

  Titan Medical Inc. announced that Cary G. Vance has been appointed as the company’s President and CEO effective July 1, 2022.

• Titan Medical Provides Update to Enos Project Timeline

  6/28/2022

  Titan Medical Inc. announced that multiple disruptions have resulted in an updated Investigational Device Exemption submission timeline for the Enos™ robotic single access surgery system.

• Titan Medical to Participate at the Society of Robotic Surgery Annual Meeting

  6/23/2022

  Titan Medical Inc. (Nasdaq :  TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced its participation at this year’s Society of Robotic Surgery (SRS) Annual Meeting.

• Titan Medical Appoints Bill Fahey as Vice President, Manufacturing and Operations

  6/6/2022

  Titan Medical Inc., a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery, announced the appointment of Bill Fahey as Vice President, Manufacturing and Operations.

• Titan Medical Announces Executive Departure

  6/1/2022

  Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced, after careful consideration and a review of the company’s future needs, that Perry Genova, Senior Vice President of Research and Product Development, will depart the company effective immediately.

• Titan Medical Reports Financial Results for the First Quarter 2022

  5/12/2022

  Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022.

• Titan Medical Announces Availability of Materials for the 2022 Annual and Special Meeting of Shareholders

  5/6/2022

  Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that its 2022 Annual and Special Meeting (“the Meeting”) is scheduled for Wednesday, June 8, 2022 at 4:00 p.m.

• Titan Medical Announces Purchase Order from Medtronic

  5/3/2022

  Titan Medical Inc. today announced receipt of a $2.6 million purchase order from Medtronic plc (NYSE: MDT), a global leader in healthcare technology.

• Titan Medical to Issue First Quarter 2022 Financial Results on May 12, 2022

  4/28/2022

  Titan Medical Inc. today announced that the company plans to issue its first quarter 2022 financial results prior to market opening on Thursday, May 12, 2022.

• Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2021

  3/24/2022

  Titan Medical Inc. today announced financial results for the three and twelve months ended December 31, 2021.

• Titan Medical to Report Year End 2021 Financial Results on March 24, 2022

  3/14/2022

  Titan Medical Inc. today announced that the company plans to issue its year end 2021 financial results prior to market opening on Thursday, March 24, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights.

• Titan Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference

  3/8/2022

  Titan Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference.

• Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy

  2/7/2022

  Titan Medical Inc. today announced that it has surpassed 200 patents and patent applications.

• Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic

  1/26/2022

  Titan Medical Inc. announced that it has received payment from Medtronic plc after successfully achieving the final milestone under the development and license agreement announced on January 4, 2022.

• Titan Medical Selects Benchmark to Manufacture Enos Robotic Single Access Surgical System

  1/11/2022

  Titan Medical Inc. announced today that it has signed a manufacturing and supply agreement with Benchmark Electronics, Inc. (NYSE: BHE) to produce Titan’s innovative Enos™ robotic single access surgical system workstations and patient carts.